We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 0.52% | 38.40 | 38.30 | 38.50 | 38.50 | 38.30 | 38.50 | 350,313 | 08:06:39 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.45 | 122.45M |
TIDMACRL
RNS Number : 1523X
Accrol Group Holdings PLC
25 April 2019
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
For immediate release: 25 April 2019
Accrol Group Holdings plc
(AIM: ACRL)
Director's Dealing
Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, announces that, Dan Wright, Executive Chairman of Accrol has today purchased 607,500 ordinary shares of GBP0.001 each ("Ordinary Shares") at a price of 24.5p per Ordinary Share. Following this purchase, he now holds 3,077,808 Ordinary Shares representing 1.58% of the current Issued Share Capital of the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Dan Wright --------------------------------- -------------------------------- 2 Reason for the notification ------------------------------------------------------------------- a) Position/status Executive Chairman --------------------------------- -------------------------------- b) Initial notification Initial notification /Amendment --------------------------------- -------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------- a) Name Accrol Group Holdings plc --------------------------------- -------------------------------- b) LEI 213800MC56M5G69RJ226 --------------------------------- -------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------- a) Description Ordinary shares of GBP0.001 of the financial instrument, ISIN: GB00BZ6VT592 type of instrument Identification code --------------------------------- -------------------------------- b) Nature of the Purchase of Ordinary Shares transaction --------------------------------- -------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) 24.5p 607,500 --------------------------------- ------------- ----------------- d) Aggregated information - Aggregated N/A - single transaction volume - Price --------------------------------- -------------------------------- e) Date of the 25 April 2019 transaction --------------------------------- -------------------------------- f) Place of the London Stock Exchange, AIM transaction --------------------------------- --------------------------------
Enquiries:
For further information, please contact: Accrol Group Holdings plc Dan Wright, Executive Chairman +44 (0) 1254 278 844 Gareth Jenkins, Chief Executive Officer +44 (0) 1254 278 844 Zeus Capital Limited (Nominated Adviser & Broker) Dan Bate / Andrew Jones +44 (0) 161 831 1512 Dominic King / John Goold +44 (0) 203 829 5000 Belvedere Communications Limited Cat Valentine (cvalentine@belvederepr.com) +44 (0) 7715 769 078 Keeley Clarke (kclarke@belvederepr.com) +44 (0) 7967 816 525 Llew Angus (langus@belvederepr.com) +44 (0) 7407 023 147
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.
Accrol operates from three sites:
-- A manufacturing, storage and distribution facility in Blackburn; -- A facial tissue plant, also in Blackburn; and -- A manufacturing, storage and distribution facility in Leyland.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLLFFESAIEFIA
(END) Dow Jones Newswires
April 25, 2019 11:32 ET (15:32 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions